ESC Premium Access

Single-center experience with different regimes of antiplatelet therapy and oral anticoagulation in transcatheter aortic valve replacement


About the speaker

Assistant Professor Verena Veulemans

University Hospital Duesseldorf, Duesseldorf (Germany)
0 follower

5 more presentations in this session

Clinical characteristics and outcomes after TAVI in patients reclassified to moderate aortic stenosis by integration of multimodality imaging and pressure recovery

Speaker: Doctor E. Holy (Zurich, CH)


Contemporary trends and outcomes of percutaneous vs. surgical aortic valve replacement in cancer patients.

Speaker: Doctor A. Guha (Cleveland, US)


Determinants of left ventricular ATP availability measured in vivo and ex vivo in patients with severe aortic stenosis: correlation of creatine kinase activity with LVEF and ATP diffusion distance

Speaker: Doctor M. Peterzan (London, GB)


Predictors of short- and mid-term outcomes after TAVR in low-flow, low-gradient aortic stenosis

Speaker: Doctor V. Emer Egypto Rosa (Sao Paulo, BR)


Left-sided deviation and fibrous-fatty infiltration of the right bundle branch in the elderly: implication for transcatheter aortic valve implantation (TAVI) procedure

Speaker: Professor J. Cabrera (Madrid, ES)


Access the full session

Aortic valve replacement: diagnostic and treatment considerations

Speakers: Assistant Professor V. Veulemans, Doctor E. Holy, Doctor A. Guha, Doctor M. Peterzan, Doctor V. Emer Egypto Rosa...

About the event



31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk